rosuvastatin/valsartan
/ EMS
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 24, 2021
Fixed-dose Combination of Valsartan + Rosuvastatin Versus Their Isolated Components for Hypertension and Dyslipidemia.
(clinicaltrials.gov)
- P3; N=0; Withdrawn; Sponsor: EMS; N=632 ➔ 0; Not yet recruiting ➔ Withdrawn
Clinical • Enrollment change • Trial withdrawal • Dyslipidemia • Hypertension • Metabolic Disorders
1 to 1
Of
1
Go to page
1